Healthcare Co.,Ltd. (SHA:603313)
China · Delayed Price · Currency is CNY 9.17
-0.81 (-8.12%)
Feb 2, 2026, 3:00 PM CST
Healthcare Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 8,862 | 8,232 | 7,759 | 7,786 | 7,912 | 6,354 |
Other Revenue | 217.37 | 217.37 | 217.21 | 231.56 | 227.36 | 176.02 |
| 9,079 | 8,449 | 7,976 | 8,017 | 8,139 | 6,530 | |
Revenue Growth (YoY) | 8.27% | 5.94% | -0.52% | -1.50% | 24.64% | 70.43% |
Cost of Revenue | 5,600 | 5,357 | 4,948 | 5,547 | 5,876 | 4,349 |
Gross Profit | 3,479 | 3,092 | 3,028 | 2,471 | 2,263 | 2,181 |
Selling, General & Admin | 2,899 | 2,526 | 2,300 | 2,032 | 1,947 | 1,309 |
Research & Development | 143.48 | 141.51 | 115.66 | 95.31 | 124.25 | 110.16 |
Other Operating Expenses | 41.58 | 42.42 | 47.41 | 46.53 | 30.38 | 25.63 |
Operating Expenses | 3,192 | 3,084 | 2,545 | 2,213 | 2,157 | 1,480 |
Operating Income | 287.24 | 7.91 | 482.9 | 257.36 | 106.66 | 701.68 |
Interest Expense | -149.91 | -181.99 | -214.03 | -182.32 | -140.52 | -80.26 |
Interest & Investment Income | 12.69 | 11.75 | 3.63 | 50.88 | 21.29 | 19.65 |
Currency Exchange Gain (Loss) | 23.92 | 23.92 | 33.61 | 120.64 | -72.14 | -105.27 |
Other Non Operating Income (Expenses) | 39.76 | -14.34 | -139.43 | -124.37 | -149.75 | -81.68 |
EBT Excluding Unusual Items | 213.71 | -152.75 | 166.68 | 122.2 | -234.45 | 454.13 |
Impairment of Goodwill | -37.57 | -37.57 | -9.53 | -2.24 | -0.46 | -0.41 |
Gain (Loss) on Sale of Investments | 7.14 | -7.93 | -12.5 | -29 | 4.52 | 25.6 |
Gain (Loss) on Sale of Assets | 14.82 | 15.74 | -0.04 | -2.88 | -4.8 | -0.69 |
Asset Writedown | 1.52 | - | -4.23 | - | - | - |
Legal Settlements | - | - | - | - | -108.26 | - |
Other Unusual Items | 19.3 | 17.52 | 24.02 | -6.71 | 69.13 | -4.46 |
Pretax Income | 219.67 | -164.25 | 164.47 | 81.37 | -274.16 | 474.59 |
Income Tax Expense | 78.16 | 14.71 | 42.93 | 29.4 | -4.53 | 57.94 |
Earnings From Continuing Operations | 141.51 | -178.96 | 121.54 | 51.97 | -269.64 | 416.65 |
Minority Interest in Earnings | 20.95 | 27.54 | -14.94 | -10.61 | -5.89 | -38.07 |
Net Income | 162.46 | -151.42 | 106.6 | 41.36 | -275.53 | 378.59 |
Net Income to Common | 162.46 | -151.42 | 106.6 | 41.36 | -275.53 | 378.59 |
Net Income Growth | - | - | 157.74% | - | - | 1.31% |
Shares Outstanding (Basic) | 567 | 561 | 485 | 460 | 483 | 443 |
Shares Outstanding (Diluted) | 567 | 561 | 485 | 460 | 483 | 447 |
Shares Change (YoY) | 4.73% | 15.74% | 5.44% | -4.93% | 8.04% | 4.07% |
EPS (Basic) | 0.29 | -0.27 | 0.22 | 0.09 | -0.57 | 0.85 |
EPS (Diluted) | 0.29 | -0.27 | 0.22 | 0.09 | -0.57 | 0.85 |
EPS Growth | - | - | 144.44% | - | - | -2.65% |
Free Cash Flow | 824.25 | 584.57 | 502.1 | -65.68 | -471.52 | -332.91 |
Free Cash Flow Per Share | 1.45 | 1.04 | 1.04 | -0.14 | -0.97 | -0.74 |
Dividend Per Share | - | 0.050 | - | - | - | 0.269 |
Gross Margin | 38.32% | 36.60% | 37.96% | 30.82% | 27.81% | 33.40% |
Operating Margin | 3.16% | 0.09% | 6.05% | 3.21% | 1.31% | 10.75% |
Profit Margin | 1.79% | -1.79% | 1.34% | 0.52% | -3.38% | 5.80% |
Free Cash Flow Margin | 9.08% | 6.92% | 6.30% | -0.82% | -5.79% | -5.10% |
EBITDA | 856.54 | 549.94 | 988.58 | 493.78 | 295.53 | 834.65 |
EBITDA Margin | 9.43% | 6.51% | 12.39% | 6.16% | 3.63% | 12.78% |
D&A For EBITDA | 569.3 | 542.03 | 505.67 | 236.42 | 188.86 | 132.97 |
EBIT | 287.24 | 7.91 | 482.9 | 257.36 | 106.66 | 701.68 |
EBIT Margin | 3.16% | 0.09% | 6.05% | 3.21% | 1.31% | 10.75% |
Effective Tax Rate | 35.58% | - | 26.10% | 36.13% | - | 12.21% |
Revenue as Reported | 9,079 | 8,449 | 7,976 | 8,017 | 8,139 | 6,530 |
Advertising Expenses | - | 281.14 | 227.4 | 190.11 | 196.31 | 143.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.